Bank of America
RPRX icon

Bank of America’s Royalty Pharma RPRX Stock Holding History

Bank of America’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,000
Closed -$1.56M – 8634
2025
Q1 		$1.56M Buy
+50,000
New +$1.58M ﹤0.01% 4895

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America's RPRX Position: Q1 2026 in Review

Bank of America increased its Royalty Pharma (RPRX) stake by 29% in Q1 2026, buying an estimated $34.5M and bringing the position to 3,495,846 shares worth $168M. The position accounts for 0.01% of the portfolio, ranked #823.

Bank of America first reported a position in RPRX in Q2 2020 and has held it in 24 quarters since. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Bank of America held 3,495,846 shares of Royalty Pharma worth $168M as of Q1 2026.
  • Bank of America bought 786,921 Royalty Pharma shares in Q1 2026, an estimated $34.5M.
  • Royalty Pharma made up 0.01% of Bank of America's portfolio in Q1 2026, its #823 holding.
  • Bank of America first reported a position in Royalty Pharma in Q2 2020 and has held it in 24 quarters since.
  • 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.